Eli Lilly

Organization

American pharmaceutical company that developed donanemab

6 stories

Experimental Drug Shows First-Ever Reduction in Tau Pathology and Cognitive Benefit in Early Alzheimer's Trial

Study Finds GLP-1 Weight-Loss Drugs May Cause Less Muscle Loss Than Previously Believed

GLP-1 Drugs Show Health Benefits for Patients Who Do Not Lose Weight

AI Analysis of 400,000 Reddit Posts Identifies Previously Overlooked GLP-1 Drug Side Effects

business72d ago

Hims & Hers Stock Surges Amid Weight-Loss Drug Battle with Novo Nordisk

GLP-1 Weight-Loss Drugs Linked to Bone and Tendon Injuries